ArticleDiagnostics (Basel, Switzerland)2020

Intratumoral Genomic Heterogeneity May Hinder Precision Medicine Strategies in Patients with Serous Ovarian Carcinoma.

Kohei Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.